20:33 , Jul 25, 2017 |  BC Innovations  |  Distillery Therapeutics

Endocrine / Metabolic

INDICATION: Obesity In vitro and mouse studies suggest a modified NMU peptide that agonizes NMUR2 could help treat obesity. The agonist consisted of a PEGylated, eight amino acid from the NMU C-terminus containing a napthylalanine...